- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04232995
Balance Training in Diabetic Neuropathy
August 18, 2021 updated by: Rabeiya Tazeem, Dow University of Health Sciences
Efficacy of Balance Training in Comparison to General Exercises Alone in Diabetic Neuropathy
This study evaluates the efficacy of balance training in Diabetic Neuropathy.
Control group will receive general exercises while Eperimental/ Interventional group will receive Balance exercises along with general exercises.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74200
- Institute of physical medicine and rehabilitation, Dow University of health sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age group: 30-60 years
- Diabetes type II patients diagnosed with peripheral neuropathy by medical doctor for at least 5 years
- Neuropathy present (on the basis of Michigan Neuropathy Screening Instrument
- Have balance impairment ( evaluation on Berg Balance Scale)
Exclusion Criteria:
- Neuropathy due to other medical conditions like Vitamin deficiency, Hypothyroidism, Auto-immune/ demyelinating diseases
- Foot ulcers
- Lower limb amputee
- Vestibular diseases
- Retinopathy
- Cardiac problems
- Hemiplegia/ Stroke
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Experimental Group
Balance training by 9 positions with 1 min hold, repeated twice
5) Forward Reaching 6) & 7) Single Leg Standing, with Right and Left foot alternately 8) & 9) Step up, with Right and Left foot alternately General Exercises for 25 min
No. Of Sessions 24, thrice a week for 8 weeks |
Balance enhancing exercises
General Exercises
|
ACTIVE_COMPARATOR: Control Group
General Exercises for 25 min
No. Of Sessions 24, thrice a week for 8 weeks |
General Exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berg Balance Scale
Time Frame: Baseline (Pre treatment)
|
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks.
Katherine Berg developed this test to assess the level of function and balance in various patient populations.
Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
|
Baseline (Pre treatment)
|
Berg Balance Scale
Time Frame: At 4th week of treatment
|
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks.
Katherine Berg developed this test to assess the level of function and balance in various patient populations.
Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
|
At 4th week of treatment
|
Berg Balance Scale
Time Frame: At 8th week of treatment (Post treatment )
|
The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks.
Katherine Berg developed this test to assess the level of function and balance in various patient populations.
Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)
|
At 8th week of treatment (Post treatment )
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 12, 2019
Primary Completion (ACTUAL)
September 1, 2020
Study Completion (ACTUAL)
November 1, 2020
Study Registration Dates
First Submitted
January 11, 2020
First Submitted That Met QC Criteria
January 15, 2020
First Posted (ACTUAL)
January 18, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 19, 2021
Last Update Submitted That Met QC Criteria
August 18, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RTazeem
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Neuropathy With Neurologic Complication
-
Eastern Virginia Medical SchoolUnknownSweat Gland Diseases | Autonomic Nervous System Diseases | Diabetic Neuropathy With Neurologic ComplicationUnited States
-
Imperial College LondonActegy Ltd.Not yet recruitingDiabetic Neuropathies | Diabetic Peripheral Neuropathy | Diabetic Polyneuropathy | Diabetic ComplicationUnited Kingdom
-
BayerTerminatedNeuropathic Pain Associated With Diabetic Peripheral NeuropathyGermany, Denmark, France, Poland, Finland, Czechia, Hungary, Norway, Slovakia, Sweden
-
University of PlymouthNot yet recruitingDiabetic Peripheral Neuropathy | Painful Diabetic Neuropathy
-
Helixmith Co., Ltd.CompletedDiabetic Neuropathy, Painful | Painful Diabetic NeuropathyUnited States
-
Helixmith Co., Ltd.CompletedDiabetic Neuropathy, Painful | Painful Diabetic NeuropathyUnited States
-
AbbVie (prior sponsor, Abbott)CompletedDiabetic Neuropathies | Diabetic Neuropathy, Painful | Diabetic Polyneuropathy | Diabetic Neuralgia | Neuralgia, DiabeticUnited States, Canada, France, Germany, Italy, Mexico, Puerto Rico
-
SK Life Science, Inc.CompletedDiabetic Neuropathy, Painful | Diabetic Polyneuropathy | Diabetic Neuralgia | Diabetic Mononeuropathy
-
East Bay Institute for Research and EducationCompletedDiabetic Neuropathy, Painful | Diabetic Polyneuropathy | Diabetic Neuralgia | Diabetic MononeuropathyUnited States
-
Maastricht University Medical CenterCompletedPainful Diabetic Neuropathy | Diabetic Neuropathies, Painful | Neuralgia, DiabeticNetherlands
Clinical Trials on Balance Training
-
University GhentCompletedFunctional Ankle InstabilityBelgium
-
Riphah International UniversityCompletedIntellectual ImpairmentPakistan
-
National Yang Ming UniversityCompletedChronic Ankle InstabilityTaiwan
-
RehaClinic AGCompleted
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Al-Quds UniversityEnrolling by invitationStroke | Chronic Stroke | BalancePalestinian Territory, occupied
-
Istanbul Medipol University HospitalCompletedCognitive RehabilitationTurkey
-
VA Office of Research and DevelopmentNot yet recruiting
-
University of ManitobaSDM College of Medical Sciences & HospitalUnknown
-
Foundation University IslamabadCompleted